Christina Demopulos
Psychiatry · Mercer Island, WANPI 1942403381
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.5% of the total across 414 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 15.6% — the pattern of someone who eats at a lot of different presentations. Among psychiatry clinicians in WA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 414 payments — averaging $22.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$1K
- AbbVie$1K
- Otsuka America Pharmaceutical, Inc.$1K
- Teva Pharmaceuticals USA, Inc.$1K
- Neurocrine Biosciences, Inc.$820
- Johnson & Johnson$676
- plus $3K from 20 others
What the payments were for
- Food & beverage$9,16298%
- Education$2342%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 75 | $1,470 |
| AbbVie(2 entities) | 74 | $1,430 |
| Otsuka America Pharmaceutical, Inc. | 59 | $1,041 |
| Teva Pharmaceuticals USA, Inc. | 38 | $1,011 |
| Neurocrine Biosciences, Inc. | 23 | $820 |
| Johnson & Johnson | 23 | $676 |
| Lundbeck LLC | 25 | $500 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $344 |
| Vanda Pharmaceuticals Inc. | 11 | $300 |
| Alkermes, Inc. | 10 | $237 |
| Axsome Therapeutics, Inc. | 9 | $213 |
| Idorsia Pharmaceuticals US Inc | 11 | $204 |
| Livanova USA, Inc. | 5 | $199 |
| Avanir Pharmaceuticals, Inc. | 10 | $196 |
| Jazz Pharmaceuticals Inc. | 3 | $144 |
| E.r. Squibb & Sons, L.L.C. | 3 | $144 |
| Alfasigma USA, Inc. | 8 | $132 |
| Corium, LLC | 4 | $79 |
| Vertical Pharmaceuticals, LLC | 3 | $59 |
| Janssen Scientific Affairs, LLC | 1 | $54 |
| Merck | 2 | $38 |
| Ironshore Pharmaceuticals Inc. | 2 | $30 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $24 |
| Tris Pharma Inc | 1 | $23 |
| Collegium Pharmaceutical, Inc. | 1 | $17 |
| Sumitomo Pharma America, Inc. | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$9,396 in reported general payments places this provider in the 95th percentile of 576 psychiatry providers in Washington.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Aripiprazole | 20 | $1,116 |
| Lamotrigine | 70 | $690 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 16 | $655 |
| AmantadineAmantadine Hcl | 13 | $571 |
| Duloxetine Hcl | 22 | $392 |
| Gabapentin | 37 | $356 |
| Clonazepam | 36 | $248 |
| Escitalopram Oxalate | 21 | $223 |
| Divalproex Sodium | 11 | $217 |
| Lithium Carbonate ErLithium Carbonate | 11 | $154 |
| Quetiapine Fumarate | 19 | $104 |
| Alprazolam | 28 | $85 |
| Trazodone Hcl | 14 | $74 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Mercer Island
- David DunnerMercer Island$79K
- Cara ErkutMercer Island$14K
- Ryan FugateMercer Island$4K
- Jeffrey HansenVancouver$2.8M
- Chester RobachinskiSeattle$1.1M
- Larry BornsteinEverett$663K
- Matthew BogoyasYakima$500K
- Pablo ProanoSeattle$112K
- Jesse McClellandSeattle$39K
- Douglas WornellFox Island$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.